Motley Rice - Attorneys at Law
Navigation
Main navigation
Motley Rice represents clients across many areas.
Learn about the cases Motley Rice is actively representing clients in or cases that we've litigated previously.
Ozempic® users are filing lawsuits for vision loss, ileus, and other serious injuries.
Lawsuits allege talcum powder use is linked to reproductive organ cancer for women.
Lawsuits allege toxic heavy metals in baby food damage infants’ brain development.
Social media companies are being sued over alleged teenage mental health harms.
Meta is being sued for teenage mental health harms allegedly caused by Facebook and Instagram.
Women hurt by birth control drugs and devices may be eligible to sue over their injuries.
Studies link hair relaxers to uterine/ovarian cancer. Lawsuits seek to hold companies accountable.
Family members may have been eligible to file Camp Lejeune water contamination lawsuits.
People are filing gastroparesis lawsuits after using drugs like Ozempic®, Wegovy® and Mounjaro™.
While litigation can take years to complete from start to finish, our firm is always working for our clients, no matter how long it takes or how hard it gets.
Motley Rice attorneys and support personnel are dedicated to representing clients and working with co-counsel located throughout the United States and around the world.
Comprehensive, up-to-date news on the issues surrounding the litigation areas of Motley Rice LLC.
News, Learn about the latest happenings from lawsuits and other events impacting plaintiffs.
Motley Rice lawyers share their insights on litigation and more to inform people exploring their legal options.
This case is no longer active
Anti-Kickback Regulation: Omnicare, Inc.
The Legal Team
When an entity such as a trust or pension fund chooses to litigate alleged fraud, we know that it can be just as important to affect changes to prevent similar actions in the future as it is to recover lost investment funds.
On Oct. 28, 2013, the court granted final approval of a $16.7 million settlement to fund corporate governance measures within Omnicare, Inc., the nation’s largest nursing home pharmacy, following allegations that the company participated in illegal kickback schemes.
The U.S. Department of Justice issued an announcement in Nov. 2009 stating that Omnicare had agreed to pay $98 million to settle state and federal investigations into allegedly illegal kickback schemes. These alleged actions prompted shareholders to pursue litigation to recoup losses in stock value and to enhance corporate governance.
In April 2010, Motley Rice filed a shareholder derivative suit on behalf of our client, The Manville Personal Injury Settlement Trust, against former Omnicare president and CEO Joel Gemunder, along with other company executives and board members, for allegedly participating in illegal kickback schemes with a number of entities including its clients, a pharmaceutical provider and a pharmaceutical manufacturer.
Following significant discovery, which included analyzing 1.4 million pages of documents, the parties agreed on the $16.7 million settlement. After deducting court-awarded fees and costs, the settlement will fund corporate governance measures including an Omnicare Compliance Committee. The settlement also called for Omnicare to adopt and/or maintain corporate governance measures relating to, among other things, employee training and ensuring the appropriate flow of information to the compliance committee.
The case is Manville Personal Injury Settlement Trust v. Gemunder, No. 10-CI-01212 (Ky. Cir. Ct.) (regarding Omnicare, Inc.).
If you have questions regarding cases similar to the Manville Personal Injury Settlement Trust v. Gemunder settlement or if you would like to discuss a potential case, contact our securities team by email or call 1.800.768.4026.
*Prior results do not guarantee a similar outcome.
See more about Shareholder Derivative Actions